Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
Ginsburg SB, Algohary A, Pahwa S, Gulani V, Ponsky L, Aronen HJ, Boström PJ, Böhm M, Haynes AM, Brenner P, Delprado W, Thompson J, Pulbrock M, Taimen P, Villani R, Stricker P, Rastinehad AR, Jambor I, Madabhushi A. Ginsburg SB, et al. Among authors: algohary a. J Magn Reson Imaging. 2017 Jul;46(1):184-193. doi: 10.1002/jmri.25562. Epub 2016 Dec 19. J Magn Reson Imaging. 2017. PMID: 27990722 Free PMC article. Clinical Trial.
Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings.
Algohary A, Viswanath S, Shiradkar R, Ghose S, Pahwa S, Moses D, Jambor I, Shnier R, Böhm M, Haynes AM, Brenner P, Delprado W, Thompson J, Pulbrock M, Purysko AS, Verma S, Ponsky L, Stricker P, Madabhushi A. Algohary A, et al. J Magn Reson Imaging. 2018 Feb 22:10.1002/jmri.25983. doi: 10.1002/jmri.25983. Online ahead of print. J Magn Reson Imaging. 2018. PMID: 29469937 Free PMC article.
Combination of Peri-Tumoral and Intra-Tumoral Radiomic Features on Bi-Parametric MRI Accurately Stratifies Prostate Cancer Risk: A Multi-Site Study.
Algohary A, Shiradkar R, Pahwa S, Purysko A, Verma S, Moses D, Shnier R, Haynes AM, Delprado W, Thompson J, Tirumani S, Mahran A, Rastinehad AR, Ponsky L, Stricker PD, Madabhushi A. Algohary A, et al. Cancers (Basel). 2020 Aug 6;12(8):2200. doi: 10.3390/cancers12082200. Cancers (Basel). 2020. PMID: 32781640 Free PMC article.
A novel imaging based Nomogram for predicting post-surgical biochemical recurrence and adverse pathology of prostate cancer from pre-operative bi-parametric MRI.
Li L, Shiradkar R, Leo P, Algohary A, Fu P, Tirumani SH, Mahran A, Buzzy C, Obmann VC, Mansoori B, El-Fahmawi A, Shahait M, Tewari A, Magi-Galluzzi C, Lee D, Lal P, Ponsky L, Klein E, Purysko AS, Madabhushi A. Li L, et al. Among authors: algohary a. EBioMedicine. 2021 Jan;63:103163. doi: 10.1016/j.ebiom.2020.103163. Epub 2020 Dec 13. EBioMedicine. 2021. PMID: 33321450 Free PMC article.
Integrated framework for quantitative T2-weighted MRI analysis following prostate cancer radiotherapy.
Zacharaki EI, Breto AL, Algohary A, Wallaengen V, Gaston SM, Punnen S, Castillo P, Pattany PM, Kryvenko ON, Spieler B, Ford JC, Abramowitz MC, Dal Pra A, Pollack A, Stoyanova R. Zacharaki EI, et al. Among authors: algohary a. Phys Imaging Radiat Oncol. 2024 Oct 24;32:100660. doi: 10.1016/j.phro.2024.100660. eCollection 2024 Oct. Phys Imaging Radiat Oncol. 2024. PMID: 39563782 Free PMC article.
Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy.
Algohary A, Alhusseini M, Breto AL, Kwon D, Xu IR, Gaston SM, Castillo P, Punnen S, Spieler B, Abramowitz MC, Dal Pra A, Kryvenko ON, Pollack A, Stoyanova R. Algohary A, et al. Cancers (Basel). 2022 Sep 15;14(18):4475. doi: 10.3390/cancers14184475. Cancers (Basel). 2022. PMID: 36139635 Free PMC article.
Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI.
Stoyanova R, Zavala-Romero O, Kwon D, Breto AL, Xu IR, Algohary A, Alhusseini M, Gaston SM, Castillo P, Kryvenko ON, Davicioni E, Nahar B, Spieler B, Abramowitz MC, Dal Pra A, Parekh DJ, Punnen S, Pollack A. Stoyanova R, et al. Among authors: algohary a. Cancers (Basel). 2023 Oct 31;15(21):5240. doi: 10.3390/cancers15215240. Cancers (Basel). 2023. PMID: 37958414 Free PMC article.
HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of Progression.
Kimbel IM, Wallaengen V, Zacharaki EI, Breto AL, Algohary A, Carbohn S, Gaston SM, Soodana-Prakash N, Freitas PFS, Kryvenko ON, Castillo P, Abramowitz MC, Ritch CR, Nahar B, Gonzalgo ML, Parekh DJ, Pollack A, Punnen S, Stoyanova R. Kimbel IM, et al. Among authors: algohary a. Acad Radiol. 2024 Dec 17:S1076-6332(24)00853-5. doi: 10.1016/j.acra.2024.11.008. Online ahead of print. Acad Radiol. 2024. PMID: 39694787
18 results